Lindsay Rosenwald, Pres, CEO & COB, Director, Ten Percent Owner at Fortress Biotech, holds 320.71K shares in Journey Medical Corp (Ticker: DERM), holds 2.86M shares in Fortress Biotech (Ticker: FBIO), holds 354.32K shares in Avenue Therapeutics (Ticker: ATXI). Most recently, Lindsay Rosenwald Bought ― shares of Journey Medical Corp on Mar 27, 2024 for an estimated value of 30.40K.